We are live on ! Find out more
ACM

ACT Capital Management Portfolio holdings

AUM $153M
This Fund
S&P 500
This Quarter Est. Return
-15.78%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$71.5M
AUM Growth
-$23M
Cap. Flow
-$2.06M
Cap. Flow %
-2.89%
Top 10 Hldgs %
68.62%
Holding
96
New
11
Increased
4
Reduced
26
Closed
18

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$5.13M
2
CVX icon
Chevron
CVX
+$2.64M
3
DVN icon
Devon Energy
DVN
+$2.48M
4
U icon
Unity
U
+$1.49M
5
ET icon
Energy Transfer Partners
ET
+$1.43M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.23M
2
ARWR icon
Arrowhead Research
ARWR
+$2.48M
3
SSYS icon
Stratasys
SSYS
+$1.74M
4
LNTH icon
Lantheus
LNTH
+$1.71M
5
AIRS icon
AirSculpt Technologies
AIRS
+$942K

Sector Composition

Rank Sector Weight
1 Healthcare 66.98%
2 Energy 21.36%
3 Technology 7.65%
4 Materials 1.27%
5 Communication Services 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STAA icon
1
STAAR Surgical
STAA
$1.14B
$16.2M 22.71%
228,900
-9,200
-4% -$593K
XOM icon
2
ExxonMobil
XOM
$628B
$4.87M 6.82%
+56,900
New +$5.13M
ARWR icon
3
Arrowhead Research
ARWR
$12.2B
$4.75M 6.65%
135,000
-66,000
-33% -$2.48M
DVN icon
4
Devon Energy
DVN
$48.5B
$4.55M 6.36%
82,500
+38,000
+85% +$2.48M
KRYS icon
5
Krystal Biotech
KRYS
$9.64B
$3.87M 5.42%
59,000
– –
ARCT icon
6
Arcturus Therapeutics
ARCT
$178M
$3.57M 4.99%
226,600
-26,700
-11% -$524K
CLSD
7
DELISTED
Clearside Biomedical
CLSD
$3.36M 4.7%
152,547
-11,360
-7% -$276K
CVX icon
8
Chevron
CVX
$371B
$2.82M 3.95%
19,500
+16,000
+457% +$2.64M
ADTN icon
9
Adtran
ADTN
$641M
$2.63M 3.68%
150,000
+65,000
+76% +$1.18M
IDYA icon
10
IDEAYA Biosciences
IDYA
$3.47B
$2.39M 3.35%
173,500
– –
EIGR
11
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$1.57M 2.2%
8,333
– –
NVNO
12
enVVeno Medical
NVNO
$7.39M
$1.52M 2.12%
11,463
– –
INMB icon
13
INmune Bio
INMB
$50.5M
$1.42M 1.98%
160,500
-70,000
-30% -$521K
ET icon
14
Energy Transfer Partners
ET
$70B
$1.27M 1.78%
+127,800
New +$1.43M
U icon
15
Unity
U
$15.5B
$968K 1.35%
+26,300
New +$1.49M
SSYS icon
16
Stratasys
SSYS
$778M
$937K 1.31%
50,000
-88,500
-64% -$1.74M
VTLE
17
DELISTED
Vital Energy
VTLE
$882K 1.23%
+12,800
New +$1.03M
AFMD
18
DELISTED
Affimed
AFMD
$855K 1.2%
30,880
– –
LNTH icon
19
Lantheus
LNTH
$6.61B
$852K 1.19%
12,900
-27,100
-68% -$1.71M
ICAD
20
DELISTED
iCAD Inc
ICAD
$820K 1.15%
205,000
-89,500
-30% -$341K
MYOV
21
DELISTED
Myovant Sciences Ltd.
MYOV
$808K 1.13%
65,000
-20,000
-24% -$221K
CF icon
22
CF Industries
CF
$17.9B
$772K 1.08%
+9,000
New +$875K
IKT icon
23
Inhibikase Therapeutics
IKT
$377M
$696K 0.97%
156,250
-23,167
-13% -$137K
MRVI icon
24
Maravai LifeSciences
MRVI
$946M
$696K 0.97%
+24,500
New +$776K
AUPH icon
25
Aurinia Pharmaceuticals
AUPH
$1.95B
$513K 0.72%
51,000
-16,500
-24% -$184K
1
2 3 4

Similar funds

BCI
Blue Capital Inc Omaha, Nebraska $153M AUM 28.69% 1-Year Est. Return
APW
Atlantic Private Wealth Chapel Hill, North Carolina $153M AUM 15.75% 1-Year Est. Return
DAM
Doheny Asset Management Los Angeles, California $153M AUM 42.04% 1-Year Est. Return
BVC
Bright Valley Capital Hong Kong $153M AUM 16.24% 1-Year Est. Return
RHAM
Round Hill Asset Management Pasadena, California $153M AUM 6.67% 1-Year Est. Return
RFN
Redwood Financial Network Solon, Ohio $153M AUM 17.17% 1-Year Est. Return
SGM
Sellaronda Global Management New York $152M AUM 2.1% 1-Year Est. Return
HWM
Horizons Wealth Management Asheville, North Carolina $152M AUM 9.43% 1-Year Est. Return

ACT Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, ACT Capital Management held 96 positions worth $71.5M, down 24% from $94.5M the previous quarter. Its ten largest holdings account for 69% of the portfolio.

ACT Capital Management's Q2 2022 filing shows 11 new, 4 increased, 26 reduced and 18 closed positions. Its largest new stake was ExxonMobil: 56,900 shares worth $4.87M. The largest sale was NVIDIA, an estimated $4.23M.

By sector, the portfolio is most concentrated in Healthcare at 67% of assets, down from 76% a quarter earlier, followed by Energy and Technology.

  • ACT Capital Management's largest Q2 2022 buy was ExxonMobil: 56,900 shares worth $4.87M.
  • ACT Capital Management added most to Chevron in Q2 2022, an estimated $2.64M increase.
  • ACT Capital Management's biggest Q2 2022 reduction was Arrowhead Research, cutting an estimated $2.48M.
  • ACT Capital Management fully exited NVIDIA in Q2 2022, selling an estimated $4.23M.
  • ACT Capital Management's ten largest holdings make up 69% of its $71.5M portfolio in Q2 2022.
  • ACT Capital Management opened 11 new positions and closed 18 in Q2 2022.
  • ACT Capital Management's portfolio value fell 24% quarter-over-quarter to $71.5M.

Based on ACT Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.